Tag: opioid crisis
-
New Orleans Doctor Reframes Addiction Care: Compassion, science, and safer paths to recovery
Reframing Addiction Care in a Challenging Landscape In New Orleans, a city grappling with a long-standing opioid crisis and deep health disparities, a physician is reshaping how addiction is treated. Rather than viewing patients solely through the lens of risk or blame, this approach centers on medical science, patient dignity, and access to comprehensive care.…
-
Kratom and 7-OH: FDA Addiction Risk in the US Today
Rising popularity of kratom and 7-OH products Across the United States, kratom and its metabolite 7-OH have moved from niche herbal markets into mainstream retail spaces. Fans tout the products as natural mood boosters, energy enhancers, or alternatives to traditional pain relief. They’re increasingly found in smoke shops, head shops, and online retailers, making them…
-
Health Canada ignored expert advice to expand access to safe drugs for opioid users, internal documents show
Overview: Internal documents surface warning signs Newly obtained internal documents raise questions about Health Canada’s approach to addressing the opioid crisis. The materials suggest that expert advisors pressed for expanding access to safe drugs for opioid users—an approach many public health experts say could reduce overdoses and save lives. The documents imply a tension between…
-
Health Canada Ignored Expert Advice on Expanding Safe Drug Access
Overview: A policy standoff at Health Canada Newly disclosed internal documents raise questions about Health Canada’s approach to the ongoing opioid crisis. The materials suggest that health policy experts advised expanding access to safe, regulated drugs as a tool to reduce overdoses and save lives, but senior officials chose a more cautious path. The revelations…
-
Health Canada ignored experts on expanding safe opioid treatment
Overview: A policy clash at Health Canada New internal documents indicate that Health Canada faced pressure to broaden access to safe, regulated drugs for people who use opioids, yet senior officials reportedly did not implement or even seriously consider the expert recommendations. The controversy centers on how best to reduce overdose deaths, stabilize communities affected…